Juvenile-Onset Relapsing Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired, immune-mediated condition. It is a symmetric, motor-predominant neuropathy that results in both proximal and distal limb muscle weakness and is characterized by electrodiagnostic or pathologic features of demyelination. CIDP is a treatable disease that is known to be rare in the pediatric population. This case report describes a 12-year-old female who presented with gait disturbance and progressive upper and lower limb weakness. The electrophysiologic findings were compatible with demyelinating polyneuropathy. Combined with the clinical features, the diagnosis of CIDP was made and treatment was administered. The first-line immunomodulatory treatment seemed to be effective, as shown by improvements in electrophysiologic and clinical parameters, but the relapsing-remitting clinical course required additional immunomodulatory treatment. Herein, we describe the patient’s clinical and electrophysiologic course according to the treatment.
Abstract
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired, immune-mediated condition. It is a symmetric, motor-predominant neuropathy that results in both proximal and distal limb muscle weakness and is characterized by electrodiagnostic or pathologic features of demyelination. CIDP is a treatable disease that is known to be rare in the pediatric population. This case report describes a 12-year-old female who presented with gait disturbance and progressive upper and lower limb weakness. The electrophysiologic findings were compatible with demyelinating polyneuropathy. Combined with the clinical features, the diagnosis of CIDP was made and treatment was administered. The first-line immunomodulatory treatment seemed to be effective, as shown by improvements in electrophysiologic and clinical parameters, but the relapsing-remitting clinical course required additional immunomodulatory treatment. Herein, we describe the patient’s clinical and electrophysiologic course according to the treatment.
참고문헌 (10)
- Dyck PJB, "History, diagnosis, and management of chronic inflammatory demyelinating polyradiculoneuropathy", Mayo Clin Proc, 93, pp.777~793 (2018)
- Köller H, "Chronic inflammatory demyelinating polyneuropathy--update on pathogenesis, diagnostic criteria and therapy", Curr Opin Neurol, 18, pp.273~278 (2005)
- Connolly AM, "Chronic inflammatory demyelinating polyneuropathy in childhood", Pediatr Neurol, 24, pp.177~182 (2001)
- Van den Bergh PY, "European Federation of Neurological Societies", Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy : report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision, 2010, pp.17, 356~363
- Hattori N, "Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy", J Neurol Sci, 184, pp.57~63 (2001)
- Vallat JM, "Chronic inflammatory demyelinating polyradiculoneuropathy : diagnostic and therapeutic challenges for a treatable condition", Lancet Neurol, 9, pp.402~412 (2010)
- McMillan HJ, "Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series", Neuromuscul Disord, 23, pp.103~111 (2013)
- Gorson KC, "An update on the management of chronic inflammatory demyelinating polyneuropathy", Ther Adv Neurol Disord, 5, pp.359~373 (2012)
- Kuwabara S, "Long term prognosis of chronic inflammatory demyelinating polyneuropathy : a five year follow up of 38 cases", J Neurol Neurosurg Psychiatry, 77, pp.66~70 (2006)
- Chang MC, "Missed diagnosis of chronic inflammatory demyelinating polyneuropathy in a patient with cervical myelopathy due to ossification of posterior longitudinal ligament", Neurol Int, 10, pp.769~ (2018)